1. Medtech Insight
  2. >>Policy & Regulation

FDA Orders Custom Ultrasonics To Recall All Endoscope Reprocessors

The rare recall order comes as a result of a consent-decree violation by the company, which supplies endoscope reprocessors to almost 3,000 hospitals nationwide. FDA says Custom Ultrasonics has failed to validate its device designs, among other concerns.

FDA has ordered Custom Ultrasonics Inc. to recall of its Automated Endoscope Reprocessors (AERs) from health care facilities because the company is in violation of a 2007 consent decree, the agency announced Nov. 13.

FDA estimates 2,800 AERs manufactured by Custom Ultrasonics are now being used in hospitals and outpatient clinics throughout the United States

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Recalls

More from Policy & Regulation